The Humoral Immune Response of the ChAdOx1 nCoV-19 Vaccine in Maintenance Dialysis Patients without Prior COVID-19 Infection.

Chung-Yi ChengTe-Chao Fang Hung-Wei LiaoTso-Hsiao ChenJer-Hwa Chang Yen-Chung Lin Chih-Chin KaoMing-Che LiuHui-Wen ChangChing-Sheng HungJude Chu-Chun WangShih-Hsin HsiaoYuh-Mou Sue

Published in: Vaccines (2022)

Despite a delayed response, 94.16% of chronic dialysis patients achieved a positive antibody response after two doses of the AZ vaccine. Age is the most significant factor associated with antibody response.

Keyphrases

end stage renal disease
chronic kidney disease
immune response
peritoneal dialysis
newly diagnosed
ejection fraction
prognostic factors
patient reported outcomes
inflammatory response
patient reported
drug induced